Would you ever consider a nonoperative approach for cutaneous angiosarcoma when a patient achieves a complete or near-complete clinical response after chemoradiotherapy?
This question is part of our ASTRO 2026 collaboration, inspired by the LBA Session Presentation "A Phase II Trial of Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma" by Dr. Silpa Raju-Salicki, MD
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · UCSF Medical Center
Answered on
Some limited surgery is generally favored, especially if the original site is still present after induction chemotherapy or chemo-RT. Extensive surgery and prolonged healing times are less favored, in particular if they will become barriers to prompt adjuvant RT delivery or systemic therapy delivery...
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on
It is common for patients to achieve near-complete clinical response from induction paclitaxel alone. The robust near-complete clinical response rate from this study is unsurprising, based on the chemotherapy response expectation for this drug. Multiple studies show that patients who undergo surgery...
Join for free or sign in to see the full answer